Polyphor is a privately owned Swiss
biotech company founded in 1996.
The Small Molecules
Business Unit (SMBU) provides the pharmaceutical industry with
innovative, high quality products and services in the area of drug
discovery.
The Protein Epitope Mimetics Business Unit (PEMBU)
conducts its own drug discovery and clinical development programs based
on the proprietary PEM Technology.
Polyphor also offers PEM Technology for collaborations on customer's
targets.